Clinical Trial Update: Real-World Pharmacokinetic/Pharmacodynamic Study of Eravacycline in Critically III Patients

View source ↗

Summary

A real-world PK/PD study examining eravacycline exposure and activity in critically ill patients with infections to inform dosing in severe cases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infection
• Sepsis

Drugs mentioned

• XERAVA (eravacycline)

Snippet

Sponsor: Sichuan Provincial People's Hospital | Conditions: Eravacycline, Pharmacokinetics | Status: NOT_YET_RECRUITING